ABVC BioPharma Receives Additional $100,000 Payment from OncoX, Strengthening Licensing Revenue Strategy
ABVC BioPharma's continued licensing payments from OncoX BioPharma demonstrate the successful execution of its asset-light business model and highlight the growing value of plant-based cancer therapies in the biopharmaceutical market.
